US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

PURPOSE: The outcome and proportion of patients with bone-only (BO) metastatic breast cancer (MBC) has not been well described. We sought to describe the differential outcomes of patients with BO MBC in clinical trials and explore whether there was a discrepancy in radiographic reads between investi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Clin Oncol
المؤلفون الرئيسيون: Wedam, Suparna B., Beaver, Julia A., Amiri-Kordestani, Laleh, Bloomquist, Erik, Tang, Shenghui, Goldberg, Kirsten B., Sridhara, Rajeshwari, Ibrahim, Amna, Kim, Geoffrey, Kluetz, Paul, McKee, Amy, Pazdur, Richard
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2018
الموضوعات:
ORIGINAL REPORTS
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908220/
https://ncbi.nlm.nih.gov/pubmed/29522361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6917
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة